Cargando…
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278285/ https://www.ncbi.nlm.nih.gov/pubmed/35789375 http://dx.doi.org/10.1182/bloodadvances.2022006964 |
_version_ | 1784746154873847808 |
---|---|
author | Fresa, Alberto Autore, Francesco Piciocchi, Alfonso Catania, Gioacchino Visentin, Andrea Tomasso, Annamaria Moretti, Marina Vitale, Candida Chiarenza, Annalisa Morelli, Francesca Sportoletti, Paolo Marasca, Roberto Sapienza, Giuseppe Cuccaro, Annarosa Murru, Roberta Sanna, Alessandro Patti, Caterina Angeletti, Ilaria Coscia, Marta Trentin, Livio Pietrasanta, Daniela Innocenti, Idanna Laurenti, Luca |
author_facet | Fresa, Alberto Autore, Francesco Piciocchi, Alfonso Catania, Gioacchino Visentin, Andrea Tomasso, Annamaria Moretti, Marina Vitale, Candida Chiarenza, Annalisa Morelli, Francesca Sportoletti, Paolo Marasca, Roberto Sapienza, Giuseppe Cuccaro, Annarosa Murru, Roberta Sanna, Alessandro Patti, Caterina Angeletti, Ilaria Coscia, Marta Trentin, Livio Pietrasanta, Daniela Innocenti, Idanna Laurenti, Luca |
author_sort | Fresa, Alberto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9278285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92782852022-08-01 Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study Fresa, Alberto Autore, Francesco Piciocchi, Alfonso Catania, Gioacchino Visentin, Andrea Tomasso, Annamaria Moretti, Marina Vitale, Candida Chiarenza, Annalisa Morelli, Francesca Sportoletti, Paolo Marasca, Roberto Sapienza, Giuseppe Cuccaro, Annarosa Murru, Roberta Sanna, Alessandro Patti, Caterina Angeletti, Ilaria Coscia, Marta Trentin, Livio Pietrasanta, Daniela Innocenti, Idanna Laurenti, Luca Blood Adv Research Letter American Society of Hematology 2022-07-05 /pmc/articles/PMC9278285/ /pubmed/35789375 http://dx.doi.org/10.1182/bloodadvances.2022006964 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Research Letter Fresa, Alberto Autore, Francesco Piciocchi, Alfonso Catania, Gioacchino Visentin, Andrea Tomasso, Annamaria Moretti, Marina Vitale, Candida Chiarenza, Annalisa Morelli, Francesca Sportoletti, Paolo Marasca, Roberto Sapienza, Giuseppe Cuccaro, Annarosa Murru, Roberta Sanna, Alessandro Patti, Caterina Angeletti, Ilaria Coscia, Marta Trentin, Livio Pietrasanta, Daniela Innocenti, Idanna Laurenti, Luca Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study |
title | Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study |
title_full | Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study |
title_fullStr | Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study |
title_full_unstemmed | Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study |
title_short | Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study |
title_sort | relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter italian study |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278285/ https://www.ncbi.nlm.nih.gov/pubmed/35789375 http://dx.doi.org/10.1182/bloodadvances.2022006964 |
work_keys_str_mv | AT fresaalberto relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT autorefrancesco relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT piciocchialfonso relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT cataniagioacchino relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT visentinandrea relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT tomassoannamaria relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT morettimarina relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT vitalecandida relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT chiarenzaannalisa relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT morellifrancesca relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT sportolettipaolo relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT marascaroberto relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT sapienzagiuseppe relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT cuccaroannarosa relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT murruroberta relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT sannaalessandro relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT patticaterina relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT angelettiilaria relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT cosciamarta relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT trentinlivio relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT pietrasantadaniela relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT innocentiidanna relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy AT laurentiluca relativedoseintensityofobinutuzumabchlorambucilinchroniclymphocyticleukemiaamulticenteritalianstudy |